ReAlta Life SciencesReAlta Life Sciences
RL

ReAlta Life Sciences

Developing novel therapeutics for inflammatory and hypoxic diseases.

2016Active

About

ReAlta Life Sciences is a clinical-stage biopharmaceutical company focused on developing novel therapeutics for inflammatory and hypoxic diseases. Their lead candidate, Pegtarazimod, is being investigated for Hypoxic Ischemic Encephalopathy (HIE). The company leverages its proprietary platform to discover and develop treatments for a range of serious medical conditions.

Technology stack

detected 2026-06-15
Est. monthly stack spend~$70/mo
Emailunknown
Comments

No comments yet. Be the first to share your take.

Frequently asked

What does ReAlta Life Sciences do?

ReAlta Life Sciences is a clinical-stage biopharmaceutical company focused on developing novel therapeutics for inflammatory and hypoxic diseases. Their lead candidate, Pegtarazimod, is being investigated for Hypoxic Ischemic Encephalopathy (HIE). The company leverages its proprietary platform to discover and develop treatments for a range of serious medical conditions.

How much funding has ReAlta Life Sciences raised?

ReAlta Life Sciences has raised a total of $75M in funding. The most recent round on record is Funding Round.

Where is ReAlta Life Sciences headquartered?

ReAlta Life Sciences is headquartered in Norfolk, Virginia, USA.

When was ReAlta Life Sciences founded?

ReAlta Life Sciences was founded in 2016.

What industry does ReAlta Life Sciences operate in?

ReAlta Life Sciences operates in Biotechnology, Pharmaceuticals, Healthcare, Biotech, Drug Discovery, Clinical Trials.